aluates Reports

$ 0.0

Automative

Global Restless Legs Syndrome Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-37O3937

Global Restless Legs Syndrome Market Insights and Forecast to 2028

BUY CHAPTERS

Global Restless Legs Syndrome Market Research Report 2025

Code: QYRE-Auto-37O3937

Report

January 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Ligand Pharmaceuticals Incorporated

axxonis Pharma AG

Omeros Corporation

Manhattan Pharmaceuticals

Boehringer Ingelheim GmbH

UCB SA

Astellas

Arbor Pharmaceuticals

Jazz Pharmaceuticals, Inc.

Kyowa Hakko Kirin Co.

Restless Legs Syndrome Market

The global market for Restless Legs Syndrome was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.

Global key players of Restless Legs Syndrome include Boehringer Ingelheim GmbH, UCB SA, Astellas, Arbor Pharmaceuticals, etc.

Boehringer Ingelheim GmbH is the largest manufacturers of Restless Legs Syndrome in the world, has a share about 70%.

This report aims to provide a comprehensive presentation of the global market for Restless Legs Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Restless Legs Syndrome.

The Restless Legs Syndrome market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Restless Legs Syndrome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Restless Legs Syndrome companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Restless Legs Syndrome Market Report

Report Metric	Details
Report Name	Restless Legs Syndrome Market
Segment by Type	Pharmacological Therapy Non-Pharmacological Therapy
Segment by Application	Below 35 Years Old From 35 to 50 Years Old Above 50 Years Old
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boehringer Ingelheim GmbH, UCB SA, Astellas, Arbor Pharmaceuticals, GlaxoSmithKline plc., Ligand Pharmaceuticals Incorporated, axxonis Pharma AG, Kyowa Hakko Kirin Co., Jazz Pharmaceuticals, Inc., Omeros Corporation, Manhattan Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Restless Legs Syndrome company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Boehringer Ingelheim GmbH share in Restless Legs Syndrome Market?

Ans: Boehringer Ingelheim GmbH is the largest manufacturers of Restless Legs Syndrome in the world, has a share about 70%.

Who are the main players in the Restless Legs Syndrome Market report?

Ans: The main players in the Restless Legs Syndrome Market are Boehringer Ingelheim GmbH, UCB SA, Astellas, Arbor Pharmaceuticals, GlaxoSmithKline plc., Ligand Pharmaceuticals Incorporated, axxonis Pharma AG, Kyowa Hakko Kirin Co., Jazz Pharmaceuticals, Inc., Omeros Corporation, Manhattan Pharmaceuticals

What are the Application segmentation covered in the Restless Legs Syndrome Market report?

Ans: The Applications covered in the Restless Legs Syndrome Market report are Below 35 Years Old, From 35 to 50 Years Old, Above 50 Years Old

What are the Type segmentation covered in the Restless Legs Syndrome Market report?

Ans: The Types covered in the Restless Legs Syndrome Market report are Pharmacological Therapy, Non-Pharmacological Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Restless Legs Syndrome Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Pharmacological Therapy

1.2.3 Non-Pharmacological Therapy

1.3 Market by Application

1.3.1 Global Restless Legs Syndrome Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Below 35 Years Old

1.3.3 From 35 to 50 Years Old

1.3.4 Above 50 Years Old

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Restless Legs Syndrome Market Perspective (2020-2031)

2.2 Global Restless Legs Syndrome Growth Trends by Region

2.2.1 Global Restless Legs Syndrome Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Restless Legs Syndrome Historic Market Size by Region (2020-2025)

2.2.3 Restless Legs Syndrome Forecasted Market Size by Region (2026-2031)

2.3 Restless Legs Syndrome Market Dynamics

2.3.1 Restless Legs Syndrome Industry Trends

2.3.2 Restless Legs Syndrome Market Drivers

2.3.3 Restless Legs Syndrome Market Challenges

2.3.4 Restless Legs Syndrome Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Restless Legs Syndrome Players by Revenue

3.1.1 Global Top Restless Legs Syndrome Players by Revenue (2020-2025)

3.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2020-2025)

3.2 Global Restless Legs Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Restless Legs Syndrome Revenue

3.4 Global Restless Legs Syndrome Market Concentration Ratio

3.4.1 Global Restless Legs Syndrome Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Restless Legs Syndrome Revenue in 2024

3.5 Global Key Players of Restless Legs Syndrome Head office and Area Served

3.6 Global Key Players of Restless Legs Syndrome, Product and Application

3.7 Global Key Players of Restless Legs Syndrome, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Restless Legs Syndrome Breakdown Data by Type

4.1 Global Restless Legs Syndrome Historic Market Size by Type (2020-2025)

4.2 Global Restless Legs Syndrome Forecasted Market Size by Type (2026-2031)

5 Restless Legs Syndrome Breakdown Data by Application

5.1 Global Restless Legs Syndrome Historic Market Size by Application (2020-2025)

5.2 Global Restless Legs Syndrome Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Restless Legs Syndrome Market Size (2020-2031)

6.2 North America Restless Legs Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Restless Legs Syndrome Market Size by Country (2020-2025)

6.4 North America Restless Legs Syndrome Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Restless Legs Syndrome Market Size (2020-2031)

7.2 Europe Restless Legs Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Restless Legs Syndrome Market Size by Country (2020-2025)

7.4 Europe Restless Legs Syndrome Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Restless Legs Syndrome Market Size (2020-2031)

8.2 Asia-Pacific Restless Legs Syndrome Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Restless Legs Syndrome Market Size by Region (2020-2025)

8.4 Asia-Pacific Restless Legs Syndrome Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Restless Legs Syndrome Market Size (2020-2031)

9.2 Latin America Restless Legs Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Restless Legs Syndrome Market Size by Country (2020-2025)

9.4 Latin America Restless Legs Syndrome Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Restless Legs Syndrome Market Size (2020-2031)

10.2 Middle East & Africa Restless Legs Syndrome Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Restless Legs Syndrome Market Size by Country (2020-2025)

10.4 Middle East & Africa Restless Legs Syndrome Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Boehringer Ingelheim GmbH

11.1.1 Boehringer Ingelheim GmbH Company Details

11.1.2 Boehringer Ingelheim GmbH Business Overview

11.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Introduction

11.1.4 Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2020-2025)

11.1.5 Boehringer Ingelheim GmbH Recent Development

11.2 UCB SA

11.2.1 UCB SA Company Details

11.2.2 UCB SA Business Overview

11.2.3 UCB SA Restless Legs Syndrome Introduction

11.2.4 UCB SA Revenue in Restless Legs Syndrome Business (2020-2025)

11.2.5 UCB SA Recent Development

11.3 Astellas

11.3.1 Astellas Company Details

11.3.2 Astellas Business Overview

11.3.3 Astellas Restless Legs Syndrome Introduction

11.3.4 Astellas Revenue in Restless Legs Syndrome Business (2020-2025)

11.3.5 Astellas Recent Development

11.4 Arbor Pharmaceuticals

11.4.1 Arbor Pharmaceuticals Company Details

11.4.2 Arbor Pharmaceuticals Business Overview

11.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Introduction

11.4.4 Arbor Pharmaceuticals Revenue in Restless Legs Syndrome Business (2020-2025)

11.4.5 Arbor Pharmaceuticals Recent Development

11.5 GlaxoSmithKline plc.

11.5.1 GlaxoSmithKline plc. Company Details

11.5.2 GlaxoSmithKline plc. Business Overview

11.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Introduction

11.5.4 GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2020-2025)

11.5.5 GlaxoSmithKline plc. Recent Development

11.6 Ligand Pharmaceuticals Incorporated

11.6.1 Ligand Pharmaceuticals Incorporated Company Details

11.6.2 Ligand Pharmaceuticals Incorporated Business Overview

11.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Introduction

11.6.4 Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2020-2025)

11.6.5 Ligand Pharmaceuticals Incorporated Recent Development

11.7 axxonis Pharma AG

11.7.1 axxonis Pharma AG Company Details

11.7.2 axxonis Pharma AG Business Overview

11.7.3 axxonis Pharma AG Restless Legs Syndrome Introduction

11.7.4 axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2020-2025)

11.7.5 axxonis Pharma AG Recent Development

11.8 Kyowa Hakko Kirin Co.

11.8.1 Kyowa Hakko Kirin Co. Company Details

11.8.2 Kyowa Hakko Kirin Co. Business Overview

11.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Introduction

11.8.4 Kyowa Hakko Kirin Co. Revenue in Restless Legs Syndrome Business (2020-2025)

11.8.5 Kyowa Hakko Kirin Co. Recent Development

11.9 Jazz Pharmaceuticals, Inc.

11.9.1 Jazz Pharmaceuticals, Inc. Company Details

11.9.2 Jazz Pharmaceuticals, Inc. Business Overview

11.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Introduction

11.9.4 Jazz Pharmaceuticals, Inc. Revenue in Restless Legs Syndrome Business (2020-2025)

11.9.5 Jazz Pharmaceuticals, Inc. Recent Development

11.10 Omeros Corporation

11.10.1 Omeros Corporation Company Details

11.10.2 Omeros Corporation Business Overview

11.10.3 Omeros Corporation Restless Legs Syndrome Introduction

11.10.4 Omeros Corporation Revenue in Restless Legs Syndrome Business (2020-2025)

11.10.5 Omeros Corporation Recent Development

11.11 Manhattan Pharmaceuticals

11.11.1 Manhattan Pharmaceuticals Company Details

11.11.2 Manhattan Pharmaceuticals Business Overview

11.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Introduction

11.11.4 Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2020-2025)

11.11.5 Manhattan Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Ligand Pharmaceuticals Incorporated

axxonis Pharma AG

Omeros Corporation

Manhattan Pharmaceuticals

Boehringer Ingelheim GmbH

UCB SA

Astellas

Arbor Pharmaceuticals

Jazz Pharmaceuticals, Inc.

Kyowa Hakko Kirin Co.

List of Tables

Table 1. Global Restless Legs Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Pharmacological Therapy

Table 3. Key Players of Non-Pharmacological Therapy

Table 4. Global Restless Legs Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Restless Legs Syndrome Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Restless Legs Syndrome Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Restless Legs Syndrome Market Share by Region (2020-2025)

Table 8. Global Restless Legs Syndrome Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Restless Legs Syndrome Market Share by Region (2026-2031)

Table 10. Restless Legs Syndrome Market Trends

Table 11. Restless Legs Syndrome Market Drivers

Table 12. Restless Legs Syndrome Market Challenges

Table 13. Restless Legs Syndrome Market Restraints

Table 14. Global Restless Legs Syndrome Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Restless Legs Syndrome Market Share by Players (2020-2025)

Table 16. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2024)

Table 17. Ranking of Global Top Restless Legs Syndrome Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Restless Legs Syndrome Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Restless Legs Syndrome, Headquarters and Area Served

Table 20. Global Key Players of Restless Legs Syndrome, Product and Application

Table 21. Global Key Players of Restless Legs Syndrome, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Restless Legs Syndrome Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Restless Legs Syndrome Revenue Market Share by Type (2020-2025)

Table 25. Global Restless Legs Syndrome Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Restless Legs Syndrome Revenue Market Share by Type (2026-2031)

Table 27. Global Restless Legs Syndrome Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Restless Legs Syndrome Revenue Market Share by Application (2020-2025)

Table 29. Global Restless Legs Syndrome Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Restless Legs Syndrome Revenue Market Share by Application (2026-2031)

Table 31. North America Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Restless Legs Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Restless Legs Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Restless Legs Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Restless Legs Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Restless Legs Syndrome Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Restless Legs Syndrome Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Restless Legs Syndrome Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Restless Legs Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Restless Legs Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Restless Legs Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Restless Legs Syndrome Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Restless Legs Syndrome Market Size by Country (2026-2031) & (US$ Million)

Table 46. Boehringer Ingelheim GmbH Company Details

Table 47. Boehringer Ingelheim GmbH Business Overview

Table 48. Boehringer Ingelheim GmbH Restless Legs Syndrome Product

Table 49. Boehringer Ingelheim GmbH Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 50. Boehringer Ingelheim GmbH Recent Development

Table 51. UCB SA Company Details

Table 52. UCB SA Business Overview

Table 53. UCB SA Restless Legs Syndrome Product

Table 54. UCB SA Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 55. UCB SA Recent Development

Table 56. Astellas Company Details

Table 57. Astellas Business Overview

Table 58. Astellas Restless Legs Syndrome Product

Table 59. Astellas Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 60. Astellas Recent Development

Table 61. Arbor Pharmaceuticals Company Details

Table 62. Arbor Pharmaceuticals Business Overview

Table 63. Arbor Pharmaceuticals Restless Legs Syndrome Product

Table 64. Arbor Pharmaceuticals Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 65. Arbor Pharmaceuticals Recent Development

Table 66. GlaxoSmithKline plc. Company Details

Table 67. GlaxoSmithKline plc. Business Overview

Table 68. GlaxoSmithKline plc. Restless Legs Syndrome Product

Table 69. GlaxoSmithKline plc. Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 70. GlaxoSmithKline plc. Recent Development

Table 71. Ligand Pharmaceuticals Incorporated Company Details

Table 72. Ligand Pharmaceuticals Incorporated Business Overview

Table 73. Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product

Table 74. Ligand Pharmaceuticals Incorporated Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 75. Ligand Pharmaceuticals Incorporated Recent Development

Table 76. axxonis Pharma AG Company Details

Table 77. axxonis Pharma AG Business Overview

Table 78. axxonis Pharma AG Restless Legs Syndrome Product

Table 79. axxonis Pharma AG Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 80. axxonis Pharma AG Recent Development

Table 81. Kyowa Hakko Kirin Co. Company Details

Table 82. Kyowa Hakko Kirin Co. Business Overview

Table 83. Kyowa Hakko Kirin Co. Restless Legs Syndrome Product

Table 84. Kyowa Hakko Kirin Co. Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 85. Kyowa Hakko Kirin Co. Recent Development

Table 86. Jazz Pharmaceuticals, Inc. Company Details

Table 87. Jazz Pharmaceuticals, Inc. Business Overview

Table 88. Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Product

Table 89. Jazz Pharmaceuticals, Inc. Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 90. Jazz Pharmaceuticals, Inc. Recent Development

Table 91. Omeros Corporation Company Details

Table 92. Omeros Corporation Business Overview

Table 93. Omeros Corporation Restless Legs Syndrome Product

Table 94. Omeros Corporation Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 95. Omeros Corporation Recent Development

Table 96. Manhattan Pharmaceuticals Company Details

Table 97. Manhattan Pharmaceuticals Business Overview

Table 98. Manhattan Pharmaceuticals Restless Legs Syndrome Product

Table 99. Manhattan Pharmaceuticals Revenue in Restless Legs Syndrome Business (2020-2025) & (US$ Million)

Table 100. Manhattan Pharmaceuticals Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Restless Legs Syndrome Picture

Figure 2. Global Restless Legs Syndrome Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Restless Legs Syndrome Market Share by Type: 2024 VS 2031

Figure 4. Pharmacological Therapy Features

Figure 5. Non-Pharmacological Therapy Features

Figure 6. Global Restless Legs Syndrome Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Restless Legs Syndrome Market Share by Application: 2024 VS 2031

Figure 8. Below 35 Years Old Case Studies

Figure 9. From 35 to 50 Years Old Case Studies

Figure 10. Above 50 Years Old Case Studies

Figure 11. Restless Legs Syndrome Report Years Considered

Figure 12. Global Restless Legs Syndrome Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Restless Legs Syndrome Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Restless Legs Syndrome Market Share by Region: 2024 VS 2031

Figure 15. Global Restless Legs Syndrome Market Share by Players in 2024

Figure 16. Global Top Restless Legs Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restless Legs Syndrome as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Restless Legs Syndrome Revenue in 2024

Figure 18. North America Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Restless Legs Syndrome Market Share by Country (2020-2031)

Figure 20. United States Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Restless Legs Syndrome Market Share by Country (2020-2031)

Figure 24. Germany Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Restless Legs Syndrome Market Share by Region (2020-2031)

Figure 32. China Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Restless Legs Syndrome Market Share by Country (2020-2031)

Figure 40. Mexico Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Restless Legs Syndrome Market Share by Country (2020-2031)

Figure 44. Turkey Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Restless Legs Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Boehringer Ingelheim GmbH Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 48. UCB SA Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 49. Astellas Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 50. Arbor Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 51. GlaxoSmithKline plc. Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 52. Ligand Pharmaceuticals Incorporated Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 53. axxonis Pharma AG Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 54. Kyowa Hakko Kirin Co. Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 55. Jazz Pharmaceuticals, Inc. Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 56. Omeros Corporation Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 57. Manhattan Pharmaceuticals Revenue Growth Rate in Restless Legs Syndrome Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sleep Disorder Therapies Market Research Report 2024

Global Restless Legs Syndrome Pharmaceuticals Market Research Report 2025

Global Leg Massagers Market Research Report 2025

Global Leg Exercise Equipment Market Research Report 2025

Global Lysosomal Storage Disorder Drugs Market Research Report 2024

Global Electric Leg Foot Massagers Market Research Report 2025

Global Leg Rewinding Machine Market Research Report 2025

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Global Leg Prosthetics Market Research Report 2024

Global Leg Compression Machine Market Research Report 2025

Leg Compression Massagers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Leigh Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Syndromes Progressive Ataxia Weakness Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Leg Compression Therapy Machine Market Research Report 2024

Global Fragile X Syndrome Market Research Report 2024

Global Fatigue Detection Systems Market Research Report 2025

Global Myelodysplastic Syndrome Market Research Report 2024

Global Bedside Monitoring Systems Market Research Report 2025

Global Irritable Bowel Syndrome Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions